Candel Therapeutics, Inc. (CADL)

Candel Therapeutics Statistics

Total Valuation

CADL has a market cap or net worth of $616.57 million. The enterprise value is $520.46 million.

Market Cap	616.57M
Enterprise Value	520.46M

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

CADL has 73.27 million shares outstanding. The number of shares has increased by 51.17% in one year.

Current Share Class	73.27M
Shares Outstanding	73.27M
Shares Change (YoY)	+51.17%
Shares Change (QoQ)	+13.60%
Owned by Insiders (%)	8.16%
Owned by Institutions (%)	53.00%
Float	56.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.92
P/TBV Ratio	4.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.05, with a Debt / Equity ratio of 0.36.

Current Ratio	28.05
Quick Ratio	27.63
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.68

Financial Efficiency

Return on equity (ROE) is -51.17% and return on invested capital (ROIC) is -25.80%.

Return on Equity (ROE)	-51.17%
Return on Assets (ROA)	-23.64%
Return on Invested Capital (ROIC)	-25.80%
Return on Capital Employed (ROCE)	-28.91%
Weighted Average Cost of Capital (WACC)	1.86%
Revenue Per Employee	n/a
Profits Per Employee	-$989,491
Employee Count	55
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.50% in the last 52 weeks. The beta is -0.48, so CADL's price volatility has been lower than the market average.

Beta (5Y)	-0.48
52-Week Price Change	+52.50%
50-Day Moving Average	6.90
200-Day Moving Average	5.78
Relative Strength Index (RSI)	58.57
Average Volume (20 Days)	2,207,122

Short Selling Information

The latest short interest is 14.42 million, so 19.69% of the outstanding shares have been sold short.

Short Interest	14.42M
Short Previous Month	14.68M
Short % of Shares Out	19.69%
Short % of Float	25.41%
Short Ratio (days to cover)	6.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.33M
Pretax Income	-54.42M
Net Income	-54.42M
EBITDA	-55.58M
EBIT	-56.33M
Earnings Per Share (EPS)	-$0.97

Balance Sheet

The company has $194.83 million in cash and $49.27 million in debt, with a net cash position of $145.56 million or $1.99 per share.

Cash & Cash Equivalents	194.83M
Total Debt	49.27M
Net Cash	145.56M
Net Cash Per Share	$1.99
Equity (Book Value)	138.03M
Book Value Per Share	1.88
Working Capital	190.70M

Cash Flow

In the last 12 months, operating cash flow was -$47.73 million and capital expenditures -$1.26 million, giving a free cash flow of -$48.99 million.

Operating Cash Flow	-47.73M
Capital Expenditures	-1.26M
Depreciation & Amortization	749,000
Net Borrowing	38.71M
Free Cash Flow	-48.99M
FCF Per Share	-$0.67

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CADL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.17%
Shareholder Yield	-51.17%
Earnings Yield	-8.17%
FCF Yield	-7.36%

Analyst Forecast

The average price target for CADL is $19.63, which is 133.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.63
Price Target Difference	133.27%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2